Shanghai RAAS Blood Products Co., Ltd. (002252.SZ) — Stock Score Summary

Shanghai RAAS Blood Products Co., Ltd. (002252.SZ) has a MoatMap StockRank of 40/100 based on Quality (51/100), Value (37/100), and Momentum (39/100) factor scores. The current signal is HOLD. Shanghai RAAS is a major blood products manufacturer in China. While blood products have high barriers to entry, the business is heavily regulated and does not align with our core 18-month macro themes. Capital allocation and growth runway are insufficient for a high-conviction position.

Shanghai RAAS Blood Products Co., Ltd. researches, develops, and manufactures plasma-derived biopharmaceuticals, including albumin and immunoglobulin. It operates a vast network of plasma collection stations under strict government licenses, creating a high-barrier oligopoly in China's blood products market. The company is a leading domestic biotechnology firm with high profitability and strict regulatory protection.

Key Financial Metrics

Price$0.75
Market Cap$5.2B
P/E (TTM)26.00
P/E (Forward)14.44
Price/Book1.05
Return on Equity4.1%
Return on Invested Capital5.6%
Debt/Equity12.16
Gross Margin36.2%
Operating Margin21.6%
Revenue Growth-24.7%
Dividend Yield0.9%
Free Cash Flow$-36M

Shanghai RAAS Blood Products Co., Ltd. operates in the Biotechnology industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is Shanghai RAAS Blood Products Co., Ltd.’s (002252.SZ) StockRank?
MoatMap’s StockRank for Shanghai RAAS Blood Products Co., Ltd. (002252.SZ) is 40/100, with a Hold signal. It is a composite of Quality (51), Value (37), and Momentum (39) factor ranks across MoatMap’s 19,000+ stock universe.
Does Shanghai RAAS Blood Products Co., Ltd. have an economic moat?
Shanghai RAAS Blood Products Co., Ltd. (002252.SZ) has a Quality factor score of 51/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Shanghai RAAS Blood Products Co., Ltd. a buy, hold, or sell?
MoatMap’s current signal for Shanghai RAAS Blood Products Co., Ltd. (002252.SZ) is Hold, based on a StockRank of 40/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Shanghai RAAS Blood Products Co., Ltd. in?
Shanghai RAAS Blood Products Co., Ltd. (002252.SZ) operates in the Healthcare sector, specifically the Biotechnology industry (China).
Browse all ranked stocks002252.SZ deep dive reportAI ChampionsHow we score stocksSense-check another stock